Posted by Clinical Lab Products | Jul 3, 2005 | Cancer, Flow Cytometry |
By Nicholas Borgert As a diagnostic for detecting, analyzing, and monitoring a variety of cancers in adults and children, flow cytometry has gained universal acceptance. But the implementation and ongoing costs of this advanced technology are a m
Read MorePosted by Clinical Lab Products | Jun 10, 2005 | Cancer, Miscellaneous |
Nanogen and Pathway Diagnostics Sign License Agreement In an effort to develop optimal drug regimens and dosing strategies for therapeutic options used by patients suffering from psychiatric diseases, Nanogen Inc and Pathway Diagnostics have ente
Read MorePosted by Clinical Lab Products | Apr 10, 2005 | Cancer, Miscellaneous |
COLA Announces New QMS Accreditation Program COLA has launched a quality management systems (QMS) accreditation program to assist laboratories faced with the challenge of maintaining a culture of quality. The program is a systems-based management
Read MorePosted by Clinical Lab Products | Apr 5, 2005 | Flow Cytometry, Flow Cytometry Instruments, Lab Automation |
By Nicholas Borgert In the months since receiving clearance to launch its BD FACSCanto™ flow cytometer to the United States’ in vitro diagnostics market, Becton, Dickinson and Company (BD) has made a significant impact. After building a
Read MorePosted by Clinical Lab Products | Mar 10, 2005 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
Eaton Provides Power Supply Option for Laboratories Events such as the rolling blackouts that occurred throughout California during the first few weeks of 2001, and the massive power outages that took place in the e
Read More